Brahma Capital is a United States-focused venture capital and private investment firm founded by Sundeep Agrawal in 2019. It targets inefficient sectors and co-invests with biotech investment firms, with a focus on biotechnology, life sciences, oncology and pharmaceuticals. The firm has acted as a co-lead investor and is relevant to early- and later-stage companies raising private venture capital in the United States.